FOI release

ADR data Ludiomil (maprotiline)

Case reference FOI2025/00744

Received 18 July 2025

Published 9 September 2025

Request

I am requesting further information and want all effects on Ludiomil (maprotiline). Specifically after the following Intended effects Dementia effects Side effects

Response

See attached

Documents

• DAP guidance (004).pdf (119.5 KB)
• FOI2025_00744 (redacted).pdf (957.9 KB)
• Ludiomil Leaflet.pdf (315.7 KB)
• Ludiomil SPC.pdf (48.0 KB)
• Maprotiline DRUG ANALYSIS PRINT Up to and including 04.08.25.pdf (214.3 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.